384 related articles for article (PubMed ID: 20671744)
1. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients.
Mittman N; Desiraju B; Fazil I; Kapupara H; Chattopadhyay J; Jani CM; Avram MM
Kidney Int Suppl; 2010 Aug; (117):S41-5. PubMed ID: 20671744
[TBL] [Abstract][Full Text] [Related]
2. Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients.
Lee SY; Chen YC; Tsai IC; Yen CJ; Chueh SN; Chuang HF; Wu HY; Chiang CK; Cheng HT; Hung KY; Huang JW
PLoS One; 2013; 8(3):e57762. PubMed ID: 23469230
[TBL] [Abstract][Full Text] [Related]
3. The Benefit of a Glucose-Sparing PD Therapy on Glycemic Control Measured by Serum Fructosamine in Diabetic Patients in a Randomized, Controlled Trial (IMPENDIA).
Li PK; Dorval M; Johnson DW; Rutherford P; Shutov E; Story K; Bargman JM
Nephron; 2015; 129(4):233-40. PubMed ID: 25766261
[TBL] [Abstract][Full Text] [Related]
4. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
[TBL] [Abstract][Full Text] [Related]
5. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
Sany D; Elshahawy Y; Anwar W
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
[TBL] [Abstract][Full Text] [Related]
6. An Assessment of the Utility of Serum Fructosamine in the Diagnosis and Monitoring of Diabetes Mellitus.
John J; Sakarde A; Chafle J; Amle D; Jose J; Sakhare V; Rathod BD
Cureus; 2023 Jan; 15(1):e33549. PubMed ID: 36779109
[TBL] [Abstract][Full Text] [Related]
7. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis.
Gallieni M; De Salvo C; Lunati ME; Rossi A; D'Addio F; Pastore I; Sabiu G; Miglio R; Zuccotti GV; Fiorina P
Acta Diabetol; 2021 Aug; 58(8):975-981. PubMed ID: 33743082
[TBL] [Abstract][Full Text] [Related]
8. [The value of fructosamine in hemodialysis patients].
Küenburg E; Brunnbauer M; Watzinger U; Winter F; Müller MM; Graf H; Prager R
Wien Klin Wochenschr Suppl; 1990; 180():11-3; discussion 32-3. PubMed ID: 2321384
[TBL] [Abstract][Full Text] [Related]
9. Albumin-Corrected Fructosamine Predicts All-Cause and Non-CVD Mortality Among the Very Elderly Aged 80 Years or Older Without Diabetes.
Zhou J; Lv Y; Zhao F; Wei Y; Gao X; Chen C; Lu F; Liu Y; Li C; Wang J; Zhang X; Gu H; Yin Z; Cao Z; Kraus VB; Mao C; Shi X
J Gerontol A Biol Sci Med Sci; 2022 Aug; 77(8):1673-1682. PubMed ID: 34758092
[TBL] [Abstract][Full Text] [Related]
10. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
[TBL] [Abstract][Full Text] [Related]
11. The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing Hemodialysis.
Bomholt T; Rix M; Almdal T; Knop FK; Rosthøj S; Heinrich NS; Jørgensen MB; Larsson A; Hilsted L; Feldt-Rasmussen B; Hornum M
Blood Purif; 2022; 51(7):608-616. PubMed ID: 34583354
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of different glycemic control markers in total hip or knee arthroplasty: A prospective study.
Cetik RM; Azboy I; Birinci M; Ozturkmen Y; Kalyenci AS; Atilla B
Acta Orthop Traumatol Turc; 2023 Sep; 57(5):289-293. PubMed ID: 37823741
[TBL] [Abstract][Full Text] [Related]
13. Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.
Wada N; Mori K; Nakagawa C; Sawa J; Kumeda Y; Shoji T; Emoto M; Inaba M
J Diabetes Complications; 2015; 29(8):1310-3. PubMed ID: 26298521
[TBL] [Abstract][Full Text] [Related]
14. Poorly Regulated Blood Glucose in Diabetic Patients-predictor of Acute Infections.
Burekovic A; Dizdarevic-Bostandzic A; Godinjak A
Med Arch; 2014 Jun; 68(3):163-6. PubMed ID: 25568525
[TBL] [Abstract][Full Text] [Related]
15. Alternative strategies to the use of glycosylated hemoglobin in monitoring the glycemic status of diabetic patients with end-stage renal disease.
Folgueras García A; Corte Arboleya Z; Venta Obaya R
Med Clin (Barc); 2023 Feb; 160(4):145-150. PubMed ID: 35945057
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4.
Chen HS; Wu TE; Lin HD; Jap TS; Hsiao LC; Lee SH; Lin SH
Am J Kidney Dis; 2010 May; 55(5):867-74. PubMed ID: 20202728
[TBL] [Abstract][Full Text] [Related]
17. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
[TBL] [Abstract][Full Text] [Related]
19. Comparison of reliability of plasma fructosamine and glycosylated hemoglobin assays for assessing glycemic control in diabetic patients on hemodialysis.
Nunoi K; Kodama T; Sato Y; Iwase M; Yoshizumi H; Kurimoto H; Nishitani H; Nakamura S; Fujishima M
Metabolism; 1991 Sep; 40(9):986-9. PubMed ID: 1895965
[TBL] [Abstract][Full Text] [Related]
20. Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study).
Toida T; Sato Y; Nakagawa H; Komatsu H; Kikuchi M; Uezono S; Yamada K; Ishihara T; Hisanaga S; Kitamura K; Fujimoto S
Nephrology (Carlton); 2016 Mar; 21(3):236-40. PubMed ID: 26272229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
